PATENT CLAIM ANALYSIS

Application Number: 16418265
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-10
Patent Classification: ["514", "003700"]

Abstract:
Described is a composition comprising a peptide which consists of 7-17 adjacent amino acids and comprises the hexamer TX 1 EX 2 X 3 E, where X 1 , X 2 , and X 3  can be any natural or non-natural amino acid, and the peptide is cyclized and does not exhibit TNF receptor binding activity, and an inhibitor of viral neuraminidase.

Claim (Index 19):
The composition of  claim 18 , wherein the peptide is cyclized via a disulfide bridge between said C-residues.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 100.0
- Lexical Diversity: 1.43478
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13885705', '14434328', '13321460', '12269781', '12726297']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7389992479508012
- 35 USC 102 Novelty (BERT): 0.5675497471983577
- Combined Prediction Score: 0.7218542978755569
- Mean Citation Score: 294.6024000000001
- Max Citation Score: 465.86453
- Similarity Product: 317.45497471245704

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test